Beta-blocker use and mortality following ovarian cancer diagnosis: a population-based study.
Sign Up to like & getrecommendations! Published in 2019 at "Cancer epidemiology"
DOI: 10.1016/j.canep.2019.101579
Abstract: BACKGROUND Preclinical studies suggest that β-blockers could exhibit anticancer properties in ovarian cancer. Similar effects have also been reported in observational studies, but their results remain inconsistent and could be impaired by methodological limitations. This… read more here.
Keywords: diagnosis; blocker use; ovarian cancer; cancer ... See more keywords
β-Blocker use is not associated with improved clinical outcomes in women with breast cancer: a meta-analysis
Sign Up to like & getrecommendations! Published in 2020 at "Bioscience Reports"
DOI: 10.1042/bsr20200721
Abstract: Abstract Background: Evidence remains inconsistent regarding the potential influence of β-blocker (BB) use on clinical outcomes in women with breast cancer. We aimed to evaluate the association between BB and prognosis of breast cancer in… read more here.
Keywords: women breast; cancer; breast cancer; blocker use ... See more keywords
Beta-blocker use and urothelial bladder cancer survival: a Swedish register-based cohort study
Sign Up to like & getrecommendations! Published in 2022 at "Acta Oncologica"
DOI: 10.1080/0284186x.2022.2101902
Abstract: Abstract Background Recent observational studies linked β-adrenergic receptor blocker use with improved survival in patients with several cancer types, but there is no information on the potential effects of β-blockers in patients with bladder cancer.… read more here.
Keywords: bladder cancer; blocker use; cancer;
Combined effects of angiotensin receptor blocker use and physical training in hypertensive men
Sign Up to like & getrecommendations! Published in 2022 at "Clinical and Experimental Hypertension"
DOI: 10.1080/10641963.2022.2055763
Abstract: ABSTRACT Purpose Pharmacological (angiotensin II receptor type 1 receptor blocker use) and non-pharmacological treatment (physical aerobic exercise) are important strategies to reduces blood pressure and control arterial hypertension; however, only few clinical studies have evaluated… read more here.
Keywords: training; blocker use; receptor blocker; physical aerobic ... See more keywords
Assessment of β-blocker use and all-cause mortality in patients with myocardial infarction: a real-world analysis of the NHANES 1999–2018 database
Sign Up to like & getrecommendations! Published in 2025 at "Open Heart"
DOI: 10.1136/openhrt-2025-003757
Abstract: Objective To evaluate the association between β-blocker use and all-cause mortality in a real-world cohort of patients with myocardial infarction (MI). Methods This study included 2308 patients with MI from the National Health and Nutrition… read more here.
Keywords: use cause; blocker use; cause mortality; cause ... See more keywords
Abstract 4364629: Comparative Outcomes of Beta-Blocker Use in Post-Myocardial Infarction Patients with EF >40%: A Retrospective Cohort Study
Sign Up to like & getrecommendations! Published in 2025 at "Circulation"
DOI: 10.1161/circ.152.suppl_3.4364629
Abstract: Background: Beta-blockers are a mainstay of therapy following myocardial infarction (MI), particularly in patients with reduced ejection fraction (EF). However, their benefit in patients with preserved or mildly reduced EF (EF >40%) who undergo percutaneous… read more here.
Keywords: beta blocker; blocker; blocker use; hospitalization ... See more keywords
Patterns of beta-blocker use and dose optimization among ambulatory heart failure patients with reduced ejection fraction (HFrEF) attending public hospitals in Northeast Ethiopia: a multi-center cross-sectional study
Sign Up to like & getrecommendations! Published in 2025 at "BMC Cardiovascular Disorders"
DOI: 10.1186/s12872-025-04501-5
Abstract: Evidence-based beta-blockers are essential in managing heart failure with reduced ejection fraction (HFrEF) and are known to improve cardiovascular outcomes. Despite robust nascent guideline recommendations, studies indicate that beta-blockers are often underutilized or administered below… read more here.
Keywords: beta blockers; blocker use; beta blocker; beta ... See more keywords
Predictive factors for alpha blocker use after transurethral prostatectomy: Can preoperative urodynamic outcome predict alpha blocker medication after surgery?
Sign Up to like & getrecommendations! Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0274399
Abstract: Objective To analyze the diagnostic value of conducting urodynamic study (UDS) and show predictors for alpha blocker use 12 months after transurethral prostatectomy. Materials and methods Our study includes 406 participants that had a transurethral… read more here.
Keywords: surgery; blocker use; transurethral prostatectomy; blocker ... See more keywords
Long-Term Effect of β-Blocker Use on Clinical Outcomes in Postmyocardial Infarction Patients: A Systematic Review and Meta-Analysis
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2022.779462
Abstract: Background Prior studies provided inconsistent results regarding long-term effect of β-blocker use on clinical outcomes in postmyocardial infarction (MI) patients. Methods We searched for articles regarding long-term effect of β-blocker use on clinical outcomes in… read more here.
Keywords: term effect; long term; risk; blocker use ... See more keywords
Beta-Blocker-Related Atrioventricular Conduction Disorders—A Single Tertiary Referral Center Experience
Sign Up to like & getrecommendations! Published in 2022 at "Medicina"
DOI: 10.3390/medicina58020320
Abstract: Background and Objectives: Drug-related bradyarrhythmia is a well-documented major adverse event among beta-blocker users and a potential cause for hospitalization or additional interventions. Whether beta-blocker use is associated with specific bradyarrhythmia presentations, and how this… read more here.
Keywords: beta blocker; blocker use; sinus; blocker ... See more keywords
Beta-Blocker Use after Discharge in Patients with Acute Myocardial Infarction in the Contemporary Reperfusion Era
Sign Up to like & getrecommendations! Published in 2022 at "Medicina"
DOI: 10.3390/medicina58091177
Abstract: Background and objectives: The effect of beta-blocker use after discharge on patients with acute myocardial infarction (AMI) in the contemporary reperfusion era remains ambiguous. By applying meta-analysis, we sought to assess the role of beta-blockers… read more here.
Keywords: beta blocker; beta; blocker use; use discharge ... See more keywords